FARALLON CAPITAL MANAGEMENT LLC - PORTOLA PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$33,187,000
-46.5%
1,844,757
+66.9%
0.27%
-58.8%
Q2 2017$62,068,000
+311.4%
1,105,000
+187.0%
0.64%
+288.6%
Q1 2017$15,088,000
+572.4%
385,000
+285.0%
0.17%
+538.5%
Q4 2016$2,244,000100,0000.03%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fernwood Investment Management, LLC 228,873$7,475,0004.17%
PFM Health Sciences, LP 5,326,671$173,969,0003.54%
Marcus Capital, LLC 22,950$750,0002.76%
Partner Investment Management, L.P. 72,284$2,361,0002.55%
CADIAN CAPITAL MANAGEMENT, LP 1,240,944$40,529,0002.19%
HARVEY CAPITAL MANAGEMENT INC 158,580$5,179,0001.94%
SECTORAL ASSET MANAGEMENT INC 498,412$16,278,0001.78%
Everett Capital Advisors UK LLP 551,173$18,001,0001.52%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 125,210$4,089,0001.46%
Atika Capital Management LLC 113,000$3,691,0001.26%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders